{
  "id": 16656537,
  "title": "Stock Market Today, Oct. 26: Surgery Partners Skyrockets 48% on $5.7 Billion HealthSpan Acquisition",
  "url": "https://urgent.news/2026/10/26/stock-market-today-oct-26-surgery-partners-skyrockets-48-on-5-7",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-26T20:37:18.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/coverage/stock-market-today/2026/10/26/stock-market-today-oct-26-surgery-partners-skyrockets-48-on-usd5-7-billion-healthspan-acquisition/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "On October 26, Surgery Partners (SGRY) experienced a significant surge in its stock price, rising by 48% to close at $23.25 per share. The uptick in value was sparked by news of a staggering $5.7 billion all-cash acquisition of the company by HealthSpan Partners, an affiliate of Bon Secours Mercy Health. As a result, investors are closely monitoring the deal's progress, particularly the regulatory steps and the finalization timeline, which is expected to occur in the first quarter of 2027.\n\nTrading activity for SGRY was exceptionally high, with a trading volume of 58.3 million shares, a figure that exceeds its three-month average by a remarkable 1,772%. The company initially went public in 2015 and has since shown a 22% growth since its IPO. In comparison, the S&P 500 (^GSPC) closed at 7,677, marking a gain of 0.70%, while the Nasdaq Composite (^IXIC) reached a closing value of 26,169, up by 0.82%.\n\nWithin the peer group of outpatient surgical facilities and ancillary healthcare services, Tenet Healthcare (THC) saw a modest increase of 0.18% to close at $268.94, while HCA Healthcare (HCA) experienced a slight decline of 0.91%, closing at $464.74. The 48% surge in SGRY's share price, following the announcement of the acquisition, suggests that the market is optimistic about the deal going through. The current trading price for SGRY is slightly below the acquisition price, indicating that investors are expecting the transaction to proceed smoothly.\n\nWhile the acquisition presents an attractive opportunity for shareholders, the take-private offer price aligns closely with the stock's level from the previous year, suggesting that this could be a strategic \"buy-low\" opportunity for HealthSpan. For those who are SGRY shareholders, acquiring the available cash and moving forward may be the prudent course of action, especially considering that Bain Capital holds approximately 39% of SGRY's shares and has voted in favor of the deal.",
  "summary": "HealthSpan Partners agreed to buy the outpatient surgery center operator for $5.7 billion in cash, valuing shares at $23.50, today, Oct. 26, 2026.",
  "key_points": [
    "Surgery Partners stock surges 48% to close at $23.25 per share.",
    "All-cash acquisition of $5.7 billion announced by HealthSpan Partners.",
    "Deal expected to finalize in first quarter of 2027."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}